Pamela Shaw
Diamond Materials (United States)(US)Mersana Therapeutics (United States)(US)
Publications by Year
Research Areas
interferon and immune responses, Neuroblastoma Research and Treatments, Ubiquitin and proteasome pathways, Radiopharmaceutical Chemistry and Applications, HER2/EGFR in Cancer Research
Most-Cited Works
- → Studying clonal dynamics in response to cancer therapy using high-complexity barcoding(2015)521 cited
- → Effect of MWCNT size, carboxylation, and purification on in vitro and in vivo toxicity, inflammation and lung pathology(2013)156 cited
- → Autophagy deficiency in macrophages enhances NLRP3 inflammasome activity and chronic lung disease following silica exposure(2016)103 cited
- → Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses(2024)59 cited
- → Substitution of atenolol for propranolol in a case of propranolol- related depression(1982)53 cited
- → Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer(2023)35 cited